|Bid||79.61 x 3000|
|Ask||83.15 x 1100|
|Day's Range||81.17 - 81.99|
|52 Week Range||55.80 - 85.07|
|PE Ratio (TTM)||10.18|
|Earnings Date||Aug 1, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||86.06|
Stock Research Monitor: ESRX, AET, and ANTM LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on CVS sign up now at www.wallstequities.com/registration . On Thursday, July 12, 2018, ...
Shares of CVS Health and Aetna rose Thursday on a report the Department of Justice won't challenge their merger. Drugstore chain and pharmacy benefits manager CVS announced in December it would acquire health insurer Aetna for $69 billion in a deal that could reshape the health industry. Shares of CVS Health CVS and Aetna AET rose Thursday on a report the Department of Justice won't challenge their merger.
Drugstore chain and pharmacy benefits manager CVS announced in December it would acquire health insurer Aetna for $69 billion.
Express Scripts Holding Company (ESRX) (“Express Scripts”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1, 2018, after the market closes. Express Scripts is a healthcare opportunity company.
Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies.
Drug supply chain experts believe that Amazon will move as fast as it can, and will start by selling discounted drugs to cash payers.
Amazon bought internet pharmacy start-up PillPack last week for around $1 billion. Drug supply chain experts suggest that the company could target the growing niche of people who pay out-of-pocket for their meds. Now that Amazon AMZN has snapped up internet pharmacy PillPack for around $1 billion in cash , how long will it take before consumers can rely on the e-commerce giant for their medicines, as they do for groceries, clothing, books and pretty much everything else?
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent. PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for multiple complex, chronic conditions.
Walmart was in talks with PillPack for months. After a report from CNBC, Amazon stepped in with a bid for around $1 billion in cash, sources say. Walmart was poised to buy online pharmacy start-up PillPack before Amazon AMZN swooped in with a higher offer.
Sources say that PillPack and Walmart were in talks for months about an acquisition for less than $1 billion, but Walmart was dragging its feet on making a final offer.
Express Scripts Holding Company (NASDAQ:ESRX), a large-cap worth US$45.26b, comes to mind for investors seeking a strong and reliable stock investment. Big corporations are much sought after by risk-averse investorsRead More...
After briefly terminating its deal with start-up PillPack two years ago, Express Scripts is now in a similar spat with CareZone.
Express Scripts is terminating its relationship with CareZone over what it calls a contract dispute. The company says CareZone is misrepresenting itself as a retail pharmacy, even though it actually delivers by mail. CareZone disagrees and has encouraged customers to submit emails voicing their complaints.
Express Scripts' (ESRX) loss of major customers, downbeat 2018 earnings guidance and selling of shares to Cigna make it lower its credibility as an investment pick.
York Capital Management founder Jamie Dinan expects a wave of mergers now that a federal judge has ruled the AT&T-Time Warner deal can move forward.
Amazon and AT&T pursued the deal in part due to new competition from video streaming services like Netflix and Amazon.
Court approval of the AT&T-Time Warner deal now makes it more likely that similar kinds of pending mergers will go through — and there’s a good investing angle in this. The green light in the deal appears to clear the way for CVS Health’s (CVS) planned acquisition of insurer Aetna (AET), and Cigna’s (CI) pending takeover of pharmacy-benefit manager (PBM) Express Scripts (ESRX).
A federal judge's ruling late Tuesday blessing the AT&T-Time Warner merger raised hopes that the CVS-Aetna and Cigna-Express Scripts deals will win antitrust approval.
NEW YORK, June 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern ...
Health care and telecom stock futures responded after a federal judge approved AT&T's merger of Time Warner. Markets await a Fed rate policy decision on Wednesday.
Let’s talk about the popular Express Scripts Holding Company (NASDAQ:ESRX). The company’s shares saw a decent share price growth in the teens level on the NasdaqGS over the last fewRead More...